International Niemann–Pick Disease Alliance

First European site is now recruiting for VTS-270 trial in NP-C

Great news for the NP-C community – the first European trial site for VTS-270 (2-hydroxypropyl-β-cyclodextrin) for Niemann-Pick Type C1  is now recruiting! Professor Marquardt of the Universitätsklinikum in Münster is the investigator contact for this location:

CONTACT
Thorsten Marquardt, Univ. Prof. Dr.
+49 2518356494
thorsten.marquardt@ukmuenster.de

For more information please visit clinicaltrials.gov or the trial website developed by Vtesse at www.thenpcstudy.com. We’re delighted that a European site has started to recruit – in addition to the 4 sites already activated in the USA – and look forward to further announcements soon.

Join the Registry

Calling all patients and carers! We've created a global registry of all NPD patients - if you're not enrolled yet, join us now...

Think Again. Think NP-C

Join our international campaign to improve diagnosis of NP-C!